Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Evaluating the cost-effectiveness of cervical disc surgery techniques

Official title: Economic Evaluation of Anterior Cervical Discectomy With Arthroplasty Versus Anterior Cervical Discectomy With Fusion in the Surgical Treatment of Cervical Degenerative Disc Disease, a Randomized Controlled Trial

Run by Zuyderland Medisch Centrum · NCT04623593 · Data updated 2026-11-12

This study is testing which of two surgery options for neck pain from disc problems is more cost-effective and beneficial for patients.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment198 (estimated)
SponsorZuyderland Medisch Centrum
Academic / other
Locations1 site (Maastricht, Limburg)
StatusRecruiting
StartedJanuary 17, 2022
Main results expectedJune 1, 2026
Study endsJune 1, 2028
Registry record updatedJanuary 25, 2024
Trial IDNCT04623593 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 and older with single- or multilevel CDDD between C3 and C7 who exhibit symptoms of myelopathy or radiculopathy.

Probably not a fit

Patients with a traumatic origin of compression, previous cervical spine surgery, or those requiring additional stabilization are unlikely to benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to determine the cost-effectiveness of two surgical techniques for treating cervical degenerative disc disease (CDDD): anterior cervical discectomy with fusion (ACDF) and anterior cervical discectomy with arthroplasty (ACDA). The study will randomly assign patients with symptomatic CDDD to receive either ACDF or ACDA, assessing the long-term outcomes and costs associated with each technique. By comparing the incidence of adjacent segment pathology and overall healthcare costs, the trial seeks to provide clarity on the most economically viable surgical option for patients. The increasing prevalence of CDDD in the aging population underscores the importance of this evaluation.

Why it matters

Potential benefit: If successful, this study could lead to more cost-effective surgical options for patients suffering from cervical degenerative disc disease.

How similar studies have gone: While there is ongoing debate regarding the cost-effectiveness of these surgical techniques, this study aims to provide new insights, as no consensus currently exists.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Indication for anterior cervical decompression surgery.
* Single- or multilevel CDDD between C3 and C7.
* Symptoms of myelopathy, radiculopathy, or myeloradiculopathy.
* In case of pure radiculopathy: refractory to at least 6 weeks of conservative therapy.
* In case of myelopathy: symptomatic myelopathy.
* Patients ≥ 18 years of age.

Exclusion criteria

* Indication for (additional) posterior surgical approach.
* Indication for additional stabilization of the pathological segment by a plate.
* Previous ventral surgery of the cervical spine.
* Traumatic origin of the compression.
* Previous radiotherapy of the cervical spine.
* Metabolic bone disease.
* Inflammatory spinal disease: e.g., Bechterew's disease, Forestier's disease.
* Infection of the cervical spine.

Where it's running

  • Zuyderland Medical Center
    Maastricht, Limburg, Netherlands
    Recruiting

Study contacts

  • Principal investigator: Anouk Smeets, MD, PhD, Professor — Maastricht University Medical Center
  • Study coordinator: Valérie Schuermans, MD
  • Email: valerie.schuermans@mumc.nl
  • Phone: 0031433875001

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.